One of Chris Boerner’s first tours as the new CEO of Bristol Myers Squibb was of a 256,000 square-foot research facility in ...

Medtronic has secured FDA approval for its first closed-loop spinal cord stimulator, designed to take in signals from the ...

Last year was a difficult one for ex-Stanford president Marc Tessier-Lavigne, Ph.D. An investigation into his prior research ...

A $4.9 billion hole has appeared in Gilead’s pipeline. After years of setbacks, the big biotech dealt a final blow to its ...

After hanging out the for sale sign and filing for bankruptcy ear | According to Invitae the transaction covers ...

A three-year collaboration between Pfizer and the Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), has resulted in a new AI-driven drug discovery method that could ...

In recent years, artificial intelligence programs for drug design have steadily shown they can help explore far beyond just ...

Bristol Myers Squibb is the latest large pharma to wield the restructuring ax, with plans to cut $1.5 billion in costs by the ...

Cidara Therapeutics already knew that Janssen planned to hand off its obligations to their flu prophylaxis candidate to ...

Parexel has struck a multi-year deal with Palantir Technologies to integrate its artificial intelligence systems into Parexel ...

As a whole, Boston Scientific reported a 13.8% increase in quarterly revenue, for $3.86 billion in net sales. That outpaced ...

After BioMarin’s new leadership conducted a “strategic R&D asset review,” three of its “most productive” assets are being ...